Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia

Pediatrics

Volumn 128, Issue 4, 2011, Pages

  Gamaleldin, Rasha ^a   Iskander, Iman ^a   Seoud, Iman ^a   Aboraya, Hanan ^a   Aravkin, Aleksandr ^b   Sampson, Paul D ^b   Wennberg, Richard P ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acute bilirubin encephalopathy; Bilirubin encephalopathy; BIND score; Kernicterus; Neonatal hyperbilirubinemia; Risk factors for kernicterus

Indexed keywords

BILIRUBIN;

ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO INCOMPATIBILITY; BRAIN HEMATOMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HOSPITAL ADMISSION; HUMAN; KERNICTERUS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROTOXICITY; NEWBORN; NEWBORN JAUNDICE; NEWBORN MORTALITY; NEWBORN SEPSIS; PEDIATRIC HOSPITAL; POLYCYTHEMIA; PRIORITY JOURNAL; RHESUS INCOMPATIBILITY; RISK ASSESSMENT; RISK FACTOR;

EID: 80053471686     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0206     Document Type: Article

References (31)

1. American Academy of Pediatrics, Subcommittee on Neonatal Hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114(1):1138]. Pediatrics. 2004;114(1):297-316
2. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of full-term infants? Clin Perinatol. 1990;17(2):331-338
3. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics. 1993;92(5):651-657 (Pubitemid 23318984)
4. Johnson LH, Bhutani VK, Brown AK. System-based approach to the management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140(4):396-403 (Pubitemid 34494310)
5. Ip S, Glicken S, Kulig J, Obrien R, Sege R, Lau J. Management of Neonatal Hyperbilirubinemia. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2003.AHRQ publication 03-E011
6. Ip S, Chung M, Kulig J, et al American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114(1). Available at: www.pediatrics.org/cgi/content/full/114/1/e130
7. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems based approaches. J Perinatol. 2004;24(10):650-662 (Pubitemid 39405878)
8. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns [published correction appears in Pediatrics. 2006;117(4):1467]. Pediatrics. 2006;117(2):474-485 (Pubitemid 46071611)
9. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009;29(suppl 1):S25-S45
10. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics. 2003;111(6 pt 1):1303-1311 (Pubitemid 36682263)
11. Newman TB, Liljestrand P, Jeremy RJ, et al Jaundice and Infant Feeding Study Team. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med. 2006;354(18):1889-1900 (Pubitemid 43872690)
12. Kuzniewicz, M, Newman TB. Interaction of hemolysis and hyperbilirubinemia on neurodevelopmental outcomes in the collaborative perinatal project. Pediatrics. 2009;123(3):1045-1050
13. Johnson L, Brown AK, Bhutani VK. BIND: a clinical score for bilirubin induced dysfunction in newborns. Pediatr Suppl. 1999;104:746
14. van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics. 1961;28:870-876
15. Volpe JJ. Bilirubin and brain injury. In: Volpe JJ, ed. Neurology of the Newborn. 3rd ed. Philadelphia, PA: WB Saunders; 2001:490-514
16. Adler W, Lausen B. Bootstrap estimated true and false positive rates and ROC curve. Comp Stat Data Anal. 2009;53:718-729
17. R Development Core Team (2010). R: a language and environment for statistical computing [computer program]. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available at: www.Rproject.org. Accessed February 10, 2011
18. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing the performance of scoring classifiers. R package version 1.0-4 [computer program]. Available at: http://CRAN.R-project.org/package=ROCR. Accessed February 10, 2011
19. Davutoǧlu M, Garipardiç M, Güler E, Karabiber H, Erhan D. The etiology of severe neonatal hyperbilirubinemia and complications of exchange transfusion. Turk J Pediatr. 2010;52(2):163-166
20. Behjati Sh, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr. 2009;76(1):83-85
21. Sanpavat S. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai. 2005;88(5):588-592 (Pubitemid 41073251)
22. Hsia DY, Allen FH Jr, Gellis SS, Diamond LK. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to Kernicterus. N Engl J Med. 1952;247(18):668-671
23. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol. 2002;7(2):121-128 (Pubitemid 34983062)
24. Ritter DA, Kenny JD, Norton HJ, Rudolph AJ. A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants. Pediatrics. 1982;69(3):260-266 (Pubitemid 12171573)
25. Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics. 1982;69(4):481-485 (Pubitemid 12135952)
26. Ahlfors CE, Wennberg RP, Ostrow JD, Tiribelli C. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem. 2009;55(7):1288-1299
27. Wennberg RP, Ahlfors CE, Aravkin AY. Intervention guidelines for neonatal hyperbilirubinemia: an evidence based quagmire. Curr Pharm Des. 2009;15(25):2939-2944
28. Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med. 2010;15(3):157-163
29. Chen WX, Wong VC, Wong KY. Neurodevelopmental outcome of severe neonatal hemolytic hyperbilirubinemia. J Child Neurol. 2006;21(6):474-479 (Pubitemid 44069795)
30. Watchko JF, Jeffrey Maisels M. Enduring controversies in the management of hyperbilirubinemia in preterm neonates. Semin Fetal Neonatal Med. 2010;15(3):136-140
31. Sgro M, Campbell D, Barozzino T, Shah V. Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia. J Perinatol. 2011;31(6):392-396